Shweta Maniar, Global Director of Healthcare & Life Sciences Solutions at Google
In recent months, I’ve had the opportunity to speak about the potential of AI at a variety of organizations and events. Along with…
Continue Reading
What You Should Know:
– GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner.
– This system offers new capabilities for both clinical imaging and…
Continue Reading
What You Should Know:
– Arcadia® (arcadia.io), a leading data platform for healthcare, today announced the launch of two new solutions—Enhanced Benchmarks and Arcadia Vista Push—designed to help healthcare organizations improve value-based care performance and deliver…
Continue Reading
What You Should Know:
– Eko Health, a pioneer in applying artificial intelligence for early detection of heart and lung diseases, today announced the issuance of a Category III Current Procedural Terminology (CPT) code by the…
Continue Reading
What You Should Know:
– Impilo, a digital health platform revolutionizing healthcare access raises $11.5M in a Series A funding round led by Construct Capital, with participation from GC 1 Capital, One Way Ventures, 2048…
Continue Reading
Noah Nasser, CEO, datma
The healthcare industry is a wellspring of data, from electronic health records to data from wearables, health insurance claims, and a multitude of real-world data (RWD) points. While RWD has been…
Continue Reading
Jennifer Goldsack, CEO, Digital Medicine Society (DiMe)
Dr. Shubs Upadhyay, Director of Medical Quality, Ada Health
Lucy Orr-Ewing, Chief of Staff and Head of Policy, Coalition for Health AI (CHAI)
As the digital health market continues to…
Continue Reading
Juan Jose (JJ) Lopez Murphy, Head of AI and Data Science at Globant
As the AI market in healthcare soars to a projected $187.95 billion by 2030, the transformative impact of technology on patient care becomes…
Continue Reading
What You Should Know:
– Evvy, a female-founded vaginal microbiome company, is expanding access to science-backed women’s healthcare with the launch of new prescription-grade, at-home treatments for vaginal health.
– These treatments offer fast-acting relief for…
Continue Reading
The development of new drugs or medical interventions is a meticulous process involving various stages to ensure safety, efficacy, and regulatory compliance. Central to this journey are the preclinical and clinical trial phases, which…
Continue Reading
